Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Genome polyprotein (Human rhinovirus B) | BDBM50075603 ((E)-(S)-6-Carbamoyl-4-[(2R,5S)-5-cyclopentylsulfan...) | PDB MMDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 50 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc. Curated by ChEMBL | Assay Description Increased percentage of formazan production in drug treated virus infected cells to equal 50% of control drug free uninfected cells on serotype 14 | J Med Chem 42: 1203-12 (1999) Article DOI: 10.1021/jm980537b BindingDB Entry DOI: 10.7270/Q2RN3701 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Human rhinovirus B) | BDBM50075603 ((E)-(S)-6-Carbamoyl-4-[(2R,5S)-5-cyclopentylsulfan...) | PDB MMDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 180 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc. Curated by ChEMBL | Assay Description The EC50 was calculated as the concentration of drug that increased the percentage of formazan production in drug treated, virus infected cells to 50... | J Med Chem 42: 1203-12 (1999) Article DOI: 10.1021/jm980537b BindingDB Entry DOI: 10.7270/Q2RN3701 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Human rhinovirus B) | BDBM50075601 ((E)-(S)-4-((2R,5S)-2-Benzyl-5-benzyloxycarbonylami...) | PDB MMDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 360 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc. Curated by ChEMBL | Assay Description Increased percentage of formazan production in drug treated virus infected cells to equal 50% of control drug free uninfected cells on serotype 14 | J Med Chem 42: 1203-12 (1999) Article DOI: 10.1021/jm980537b BindingDB Entry DOI: 10.7270/Q2RN3701 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Human rhinovirus B) | BDBM50075600 ((E)-(S)-6-Carbamoyl-4-[(2R,5S)-5-cyclopentylsulfan...) | PDB MMDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 6 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc. Curated by ChEMBL | Assay Description Increased percentage of formazan production in drug treated virus infected cells to equal 50% of control drug free uninfected cells on serotype 14 | J Med Chem 42: 1203-12 (1999) Article DOI: 10.1021/jm980537b BindingDB Entry DOI: 10.7270/Q2RN3701 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Human rhinovirus B) | BDBM50075602 ((E)-(S)-4-((2R,5S)-2-Benzyl-5-cyclopentylsulfanylc...) | PDB MMDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 20 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc. Curated by ChEMBL | Assay Description Increased percentage of formazan production in drug treated virus infected cells to equal 50% of control drug free uninfected cells on serotype 14 | J Med Chem 42: 1203-12 (1999) Article DOI: 10.1021/jm980537b BindingDB Entry DOI: 10.7270/Q2RN3701 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Human rhinovirus B) | BDBM50075603 ((E)-(S)-6-Carbamoyl-4-[(2R,5S)-5-cyclopentylsulfan...) | PDB MMDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 180 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc. Curated by ChEMBL | Assay Description The EC50 was calculated as the concentration of drug that increased the percentage of formazan production in drug treated,virus infected cells to 50%... | J Med Chem 42: 1203-12 (1999) Article DOI: 10.1021/jm980537b BindingDB Entry DOI: 10.7270/Q2RN3701 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Human rhinovirus B) | BDBM50075604 ((E)-(S)-6-Carbamoyl-4-[(2R,5S)-5-cyclopentylsulfan...) | PDB MMDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 20 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc. Curated by ChEMBL | Assay Description Increased percentage of formazan production in drug treated virus infected cells to equal 50% of control drug free uninfected cells on serotype 14 | J Med Chem 42: 1203-12 (1999) Article DOI: 10.1021/jm980537b BindingDB Entry DOI: 10.7270/Q2RN3701 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Human rhinovirus B) | BDBM50075607 ((E)-(S)-6-Carbamoyl-4-[(2R,5S)-5-cyclopentylsulfan...) | PDB MMDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 100 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc. Curated by ChEMBL | Assay Description The EC50 was calculated as the concentration of drug that increased the percentage of formazan production in drug treated, virus infected cells to 50... | J Med Chem 42: 1203-12 (1999) Article DOI: 10.1021/jm980537b BindingDB Entry DOI: 10.7270/Q2RN3701 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Human rhinovirus B) | BDBM50075600 ((E)-(S)-6-Carbamoyl-4-[(2R,5S)-5-cyclopentylsulfan...) | PDB MMDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 60 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc. Curated by ChEMBL | Assay Description The EC50 was calculated as the concentration of drug that increased the percentage of formazan production in drug treated,virus infected cells to 50%... | J Med Chem 42: 1203-12 (1999) Article DOI: 10.1021/jm980537b BindingDB Entry DOI: 10.7270/Q2RN3701 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Human rhinovirus B) | BDBM50065606 ((E)-(S)-4-[(S)-2-((S)-2-Benzyloxycarbonylamino-4-m...) | PDB MMDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | n/a | n/a | 540 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc. Curated by ChEMBL | Assay Description Increased percentage of formazan production in drug treated virus infected cells to equal 50% of control drug free uninfected cells on serotype 14 | J Med Chem 42: 1203-12 (1999) Article DOI: 10.1021/jm980537b BindingDB Entry DOI: 10.7270/Q2RN3701 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Human rhinovirus B) | BDBM50075603 ((E)-(S)-6-Carbamoyl-4-[(2R,5S)-5-cyclopentylsulfan...) | PDB MMDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 160 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc. Curated by ChEMBL | Assay Description The EC50 was calculated as the concentration of drug that increased the percentage of formazan production in drug treated,virus infected cells to 50%... | J Med Chem 42: 1203-12 (1999) Article DOI: 10.1021/jm980537b BindingDB Entry DOI: 10.7270/Q2RN3701 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Human rhinovirus B) | BDBM50075599 ((E)-(S)-6-Carbamoyl-4-[(2R,5S)-5-cyclopentylsulfan...) | PDB MMDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 560 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc. Curated by ChEMBL | Assay Description The EC50 was calculated as the concentration of drug that increased the percentage of formazan production in drug treated,virus infected cells to 50%... | J Med Chem 42: 1203-12 (1999) Article DOI: 10.1021/jm980537b BindingDB Entry DOI: 10.7270/Q2RN3701 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Human rhinovirus B) | BDBM50075600 ((E)-(S)-6-Carbamoyl-4-[(2R,5S)-5-cyclopentylsulfan...) | PDB MMDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 130 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc. Curated by ChEMBL | Assay Description The EC50 was calculated as the concentration of drug that increased the percentage of formazan production in drug treated, virus infected cells to 50... | J Med Chem 42: 1203-12 (1999) Article DOI: 10.1021/jm980537b BindingDB Entry DOI: 10.7270/Q2RN3701 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Human rhinovirus B) | BDBM50075602 ((E)-(S)-4-((2R,5S)-2-Benzyl-5-cyclopentylsulfanylc...) | PDB MMDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 100 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc. Curated by ChEMBL | Assay Description The EC50 was calculated as the concentration of drug that increased the percentage of formazan production in drug treated, virus infected cells to 50... | J Med Chem 42: 1203-12 (1999) Article DOI: 10.1021/jm980537b BindingDB Entry DOI: 10.7270/Q2RN3701 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Human rhinovirus B) | BDBM50075599 ((E)-(S)-6-Carbamoyl-4-[(2R,5S)-5-cyclopentylsulfan...) | PDB MMDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc. Curated by ChEMBL | Assay Description The EC50 was calculated as the concentration of drug that increased the percentage of formazan production in drug treated, virus infected cells to 50... | J Med Chem 42: 1203-12 (1999) Article DOI: 10.1021/jm980537b BindingDB Entry DOI: 10.7270/Q2RN3701 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Human rhinovirus B) | BDBM50075607 ((E)-(S)-6-Carbamoyl-4-[(2R,5S)-5-cyclopentylsulfan...) | PDB MMDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 600 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc. Curated by ChEMBL | Assay Description The EC50 was calculated as the concentration of drug that increased the percentage of formazan production in drug treated,virus infected cells to 50%... | J Med Chem 42: 1203-12 (1999) Article DOI: 10.1021/jm980537b BindingDB Entry DOI: 10.7270/Q2RN3701 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Human rhinovirus B) | BDBM50075607 ((E)-(S)-6-Carbamoyl-4-[(2R,5S)-5-cyclopentylsulfan...) | PDB MMDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 1.60E+3 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc. Curated by ChEMBL | Assay Description The EC50 was calculated as the concentration of drug that increased the percentage of formazan production in drug treated,virus infected cells to 50%... | J Med Chem 42: 1203-12 (1999) Article DOI: 10.1021/jm980537b BindingDB Entry DOI: 10.7270/Q2RN3701 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Human rhinovirus B) | BDBM50075599 ((E)-(S)-6-Carbamoyl-4-[(2R,5S)-5-cyclopentylsulfan...) | PDB MMDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 160 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc. Curated by ChEMBL | Assay Description Increased percentage of formazan production in drug treated virus infected cells to equal 50% of control drug free uninfected cells on serotype 14 | J Med Chem 42: 1203-12 (1999) Article DOI: 10.1021/jm980537b BindingDB Entry DOI: 10.7270/Q2RN3701 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Human rhinovirus B) | BDBM50075606 ((E)-(S)-4-((2R,5S)-2-Benzyl-5-cyclopentylsulfanylc...) | PDB MMDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 50 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc. Curated by ChEMBL | Assay Description Increased percentage of formazan production in drug treated virus infected cells to equal 50% of control drug free uninfected cells on serotype 14 | J Med Chem 42: 1203-12 (1999) Article DOI: 10.1021/jm980537b BindingDB Entry DOI: 10.7270/Q2RN3701 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Human rhinovirus B) | BDBM50075605 ((E)-(S)-4-((2R,5S)-2-Benzyl-5-cyclopentylsulfanylc...) | PDB MMDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 190 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc. Curated by ChEMBL | Assay Description Increased percentage of formazan production in drug treated virus infected cells to equal 50% of control drug free uninfected cells on serotype 14 | J Med Chem 42: 1203-12 (1999) Article DOI: 10.1021/jm980537b BindingDB Entry DOI: 10.7270/Q2RN3701 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Human rhinovirus B) | BDBM50075607 ((E)-(S)-6-Carbamoyl-4-[(2R,5S)-5-cyclopentylsulfan...) | PDB MMDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 280 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc. Curated by ChEMBL | Assay Description Increased percentage of formazan production in drug treated virus infected cells to equal 50% of control drug free uninfected cells on serotype 14 | J Med Chem 42: 1203-12 (1999) Article DOI: 10.1021/jm980537b BindingDB Entry DOI: 10.7270/Q2RN3701 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Human rhinovirus B) | BDBM50075609 ((E)-(S)-4-((2R,5S)-2-Benzyl-5-benzylsulfanylcarbon...) | PDB MMDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 680 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc. Curated by ChEMBL | Assay Description Increased percentage of formazan production in drug treated virus infected cells to equal 50% of control drug free uninfected cells on serotype 14 | J Med Chem 42: 1203-12 (1999) Article DOI: 10.1021/jm980537b BindingDB Entry DOI: 10.7270/Q2RN3701 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Human rhinovirus B) | BDBM50075606 ((E)-(S)-4-((2R,5S)-2-Benzyl-5-cyclopentylsulfanylc...) | PDB MMDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 500 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc. Curated by ChEMBL | Assay Description The EC50 was calculated as the concentration of drug that increased the percentage of formazan production in drug treated,virus infected cells to 50%... | J Med Chem 42: 1203-12 (1999) Article DOI: 10.1021/jm980537b BindingDB Entry DOI: 10.7270/Q2RN3701 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Human rhinovirus B) | BDBM50075604 ((E)-(S)-6-Carbamoyl-4-[(2R,5S)-5-cyclopentylsulfan...) | PDB MMDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 170 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc. Curated by ChEMBL | Assay Description The EC50 was calculated as the concentration of drug that increased the percentage of formazan production in drug treated,virus infected cells to 50%... | J Med Chem 42: 1203-12 (1999) Article DOI: 10.1021/jm980537b BindingDB Entry DOI: 10.7270/Q2RN3701 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Human rhinovirus B) | BDBM50075604 ((E)-(S)-6-Carbamoyl-4-[(2R,5S)-5-cyclopentylsulfan...) | PDB MMDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 130 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc. Curated by ChEMBL | Assay Description The EC50 was calculated as the concentration of drug that increased the percentage of formazan production in drug treated, virus infected cells to 50... | J Med Chem 42: 1203-12 (1999) Article DOI: 10.1021/jm980537b BindingDB Entry DOI: 10.7270/Q2RN3701 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Human rhinovirus B) | BDBM50075602 ((E)-(S)-4-((2R,5S)-2-Benzyl-5-cyclopentylsulfanylc...) | PDB MMDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 35 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc. Curated by ChEMBL | Assay Description The EC50 was calculated as the concentration of drug that increased the percentage of formazan production in drug treated,virus infected cells to 50%... | J Med Chem 42: 1203-12 (1999) Article DOI: 10.1021/jm980537b BindingDB Entry DOI: 10.7270/Q2RN3701 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Human rhinovirus B) | BDBM50075606 ((E)-(S)-4-((2R,5S)-2-Benzyl-5-cyclopentylsulfanylc...) | PDB MMDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 430 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc. Curated by ChEMBL | Assay Description The EC50 was calculated as the concentration of drug that increased the percentage of formazan production in drug treated,virus infected cells to 50%... | J Med Chem 42: 1203-12 (1999) Article DOI: 10.1021/jm980537b BindingDB Entry DOI: 10.7270/Q2RN3701 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Human rhinovirus B) | BDBM50075608 ((E)-(S)-4-((2R,5S)-2-Benzyl-5-benzylsulfanylcarbon...) | PDB MMDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 190 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc. Curated by ChEMBL | Assay Description Increased percentage of formazan production in drug treated virus infected cells to equal 50% of control drug free uninfected cells on serotype 14 | J Med Chem 42: 1203-12 (1999) Article DOI: 10.1021/jm980537b BindingDB Entry DOI: 10.7270/Q2RN3701 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Human rhinovirus B) | BDBM50075600 ((E)-(S)-6-Carbamoyl-4-[(2R,5S)-5-cyclopentylsulfan...) | PDB MMDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 160 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc. Curated by ChEMBL | Assay Description The EC50 was calculated as the concentration of drug that increased the percentage of formazan production in drug treated,virus infected cells to 50%... | J Med Chem 42: 1203-12 (1999) Article DOI: 10.1021/jm980537b BindingDB Entry DOI: 10.7270/Q2RN3701 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Human rhinovirus B) | BDBM50075604 ((E)-(S)-6-Carbamoyl-4-[(2R,5S)-5-cyclopentylsulfan...) | PDB MMDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 160 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc. Curated by ChEMBL | Assay Description The EC50 was calculated as the concentration of drug that increased the percentage of formazan production in drug treated,virus infected cells to 50%... | J Med Chem 42: 1203-12 (1999) Article DOI: 10.1021/jm980537b BindingDB Entry DOI: 10.7270/Q2RN3701 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Human rhinovirus B) | BDBM50075606 ((E)-(S)-4-((2R,5S)-2-Benzyl-5-cyclopentylsulfanylc...) | PDB MMDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 360 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc. Curated by ChEMBL | Assay Description The EC50 was calculated as the concentration of drug that increased the percentage of formazan production in drug treated, virus infected cells to 50... | J Med Chem 42: 1203-12 (1999) Article DOI: 10.1021/jm980537b BindingDB Entry DOI: 10.7270/Q2RN3701 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Human rhinovirus B) | BDBM50075599 ((E)-(S)-6-Carbamoyl-4-[(2R,5S)-5-cyclopentylsulfan...) | PDB MMDB UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 1.40E+3 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc. Curated by ChEMBL | Assay Description The EC50 was calculated as the concentration of drug that increased the percentage of formazan production in drug treated,virus infected cells to 50%... | J Med Chem 42: 1203-12 (1999) Article DOI: 10.1021/jm980537b BindingDB Entry DOI: 10.7270/Q2RN3701 | |||||||||||
More data for this Ligand-Target Pair |